Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis buys rights for cardiovascular compound
Novartis buys rights for cardiovascular compound
Novartis buys rights for cardiovascular compound
Submitted by
admin
on February 12, 2009 - 7:26am
Source:
Hays Pharma,UK
News Tags:
Novartis
Portola Pharmaceuticals
Elinogrel
Headline:
Novartis buys rights for cardiovascular compound
Do Not Allow Advertisers to Use My Personal information
